Basit öğe kaydını göster

dc.contributor.authorOnar, Gulnihan
dc.contributor.authorKaratas, Mert Olgun
dc.contributor.authorBalcioglu, Sevgi
dc.contributor.authorTok, Tugba Taskin
dc.contributor.authorGurses, Canbolat
dc.contributor.authorKilic-Cikla, Isin
dc.contributor.authorAlici, Bulent
dc.date.accessioned2020-06-21T13:06:39Z
dc.date.available2020-06-21T13:06:39Z
dc.date.issued2018
dc.identifier.issn0277-5387
dc.identifier.urihttps://doi.org/10.1016/j.poly.2018.06.052
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11393
dc.descriptionTok, Tugba Taskin/0000-0002-0064-8400; Gurses, Canbolat/0000-0002-4085-0224; BALCIOGLU, Sevgi/0000-0003-0724-4772; TOK, Tugba TASKIN/0000-0002-0064-8400; ALICI, Bulent/0000-0001-5009-3223; Ozdemir, Namik/0000-0003-3371-9874; Ates, Burhan/0000-0001-6080-229Xen_US
dc.descriptionWOS: 000444358300003en_US
dc.description.abstractIn this study, six [Ag(NHC)(2)](+)[AgCl2](-) type silver complexes were synthesized by the reaction of corresponding carbene precursor and Ag2O. One [Ag(NHC)(2)]+NO3- type complex was synthesized by the anion exchange reaction of corresponding silver-NHC and NaNO3. The synthesized complexes were characterized by H-1 NMR, C-13 NMR and IR spectroscopic methods, and elemental analysis. X-ray crystal structure of 5a was also reported. Cytotoxicities of all compounds were evaluated against human breast (MCF-7) and colorectal (Caco-2) cancer cell lines and non-cancer mouse fibroblast (L-929) cell lines. All complexes performed stronger activity against both cancer cell lines than standard compound cisplatin while complex 3b performed nearly equal cytotoxicity to cisplatin against non-cancer L-929. Antimicrobial effects of all compounds were evaluated against Escherichia coli, Bacillus subtilis and Candida albicans and good activities were observed. The docking results indicated that complex 3b might be classified as druggable molecule in drug design. DNA binding study also demonstrates that 3b complex has an interaction ability to DNA. Combination of experimental and molecular docking results revealed that reported complexes are promising structures and deserve further research as anticancer drugs. (C) 2018 Elsevier Ltd. All rights reserved.en_US
dc.description.sponsorshipInonu University Research Fund (IUBAP Project) [2015-09 (GUD)]en_US
dc.description.sponsorshipThis study was financially supported by Inonu University Research Fund (IUBAP Project no: 2015-09 (GUD)).en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.isversionof10.1016/j.poly.2018.06.052en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSilver(I)en_US
dc.subjectN-Heterocyclic carbeneen_US
dc.subjectBenzotriazoleen_US
dc.subjectCytotoxicityen_US
dc.subjectAntimicrobialen_US
dc.titleBenzotriazole functionalized N-heterocyclic carbene-silver(I) complexes: Synthesis, cytotoxicity, antimicrobial, DNA binding, and molecular docking studiesen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume153en_US
dc.identifier.startpage31en_US
dc.identifier.endpage40en_US
dc.relation.journalPolyhedronen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster